Scientists discovered a protein secreted by a deep-sea extremophile—an organism adapted to extreme environmental ...

The ICSE board has released the latest class 9 syllabus for the new 2026-27 academic session. With the help of the syllabus, ...

NEW YORK, June 25, 2026 Nuvation Bio Inc. ("Nuvation Bio") (NYSE: NUVB), a global oncology company focused on tackling some ...

Biomods Subnautica 2 are clever DNA changes that will change your character for the better, unlocked by scanning various flora, fauna and sea creatures. But, while grabbing the first four Biomods is ...

Company to Showcase Integration of AI, Digital Batch Records, and Intelligent Robotics to Accelerate Pharmaceutical Manufacturing AGOURA HILLS, Calif., June 18, 2026 (GLOBE NEWSWIRE) -- Oncotelic ...

Oncotelic Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on the development of oncology and immunotherapy products. The Company's mission is to address high-unmet-need ...

Neural resonance theory proposes that music is not a mental image of the sounds we hear but actual physical vibrations ...

Unlock trusted, data-backed investing tools with TipRanks Premium, from analyst ratings and forecasts to breaking news and portfolio analysis. Discover high-conviction stock picks and new investing ...

As any athlete will tell you: perfect practice makes perfect. But for individuals who do not have regular access to coaches or trainers, maintaining good form can be tricky. In fact, during the ...

Early Access Hotfix 2 has arrived for Subnautica 2, bringing with it additional resource areas, adjustments to Hammerhead behaviour, and various bug fixes. This page acts as a comprehensive breakdown ...

The league start might be a week away, but today's arrival of the Path of Exile 2 0.5 patch notes is arguably when it all begins. There was some measure of consternation among the PoE 2 community in ...

SAN DIEGO--(BUSINESS WIRE)--Gossamer Bio, Inc. (NASDAQ: GOSS) (the “Company”), a biopharmaceutical company focused on the development and commercialization of seralutinib for the treatment of ...